Editorial: Thymus research and development: a new look at the past, current knowledge, and future perspectives [0.03%]
editorial:胸腺研究与发展：对过去的回顾、当前的认识及未来的展望
Valentin P Shichkin,Miho Shinzawa,Dominik Filipp et al.
Valentin P Shichkin et al.
Correction: Editorial: Advances in organ-specific autoimmune response: from basics to clinics [0.03%]
corrections：述评：器官特异性自身免疫反应研究进展：从基础到临床
Fan Xiao,Xuming Tang,Kongyang Ma et al.
Fan Xiao et al.
[This corrects the article DOI: 10.3389/fimmu.2024.1394736.]. Keywords: autoimmune disease; diagnosis; organ...
Published Erratum
Frontiers in immunology. 2026 Jul 15:17:1926718. DOI:10.3389/fimmu.2026.1926718 2026
Correction: Machine learning to predict distant metastasis and prognostic analysis of moderately differentiated gastric adenocarcinoma patients: a novel focus on lymph node indicators [0.03%]
纠正：用于预测中分化胃腺癌远处转移的机器学习模型及其预后分析：一个新的淋巴结指标焦点
Frontiers Production Office
Frontiers Production Office
[This corrects the article DOI: 10.3389/fimmu.2024.1398685.]. Keywords: SCUBA; autonomic nervous system; bra...
Published Erratum
Frontiers in immunology. 2026 Jul 15:17:1932683. DOI:10.3389/fimmu.2026.1932683 2026
Correction: NAT10: a potential factor to reverse tumor chemotherapy resistance and radioresistance (Review) [0.03%]
纠正:NAT10: 逆转肿瘤化疗耐药和放疗耐药的潜在因素(综述)
Frontiers Production Office
Frontiers Production Office
[This corrects the article DOI: 10.3389/fimmu.2026.1777527.]. Keywords: DNA damage repair; NAT10; RNA acetyl...
Published Erratum
Frontiers in immunology. 2026 Jul 15:17:1928728. DOI:10.3389/fimmu.2026.1928728 2026
Frequency-selective thymic programming by early-life cold stress requires interferon regulatory factor 5 [0.03%]
早期生活经历的寒冷刺激选择性地编程胸腺分化需要干扰素调节因子5
Shengnan Wang,Liyuan Li,Haokun Li et al.
Shengnan Wang et al.
Background: Early-life environmental stressors can program immune development, but how the frequency of cold stress shapes thymic programming remains unknown. ...
Staining patterns of autoantibodies in indirect immunofluorescence for autoimmune diseases of the digestive system: morphological characteristics and clinical significance [0.03%]
自身免疫性消化系统疾病的间接免疫荧光法自身抗体染色模式：形态特征及临床意义
Xiuying Shi,Xu Han,Yusi Liu et al.
Xiuying Shi et al.
Autoantibody detection is integral to the laboratory diagnosis of autoimmune diseases (AIDs). Notwithstanding the advent of a multiplicity of quantitative alternative methodologies, indirect immunofluorescence (IIF) remains the gold standar...
Single-cell profiling uncovers extracellular vesicle-associated malignant plasma cell subpopulations driving multiple myeloma progression [0.03%]
单细胞分析识别驱动多发性骨髓瘤进展的恶性浆细胞亚群及其相关细胞外囊泡
Lu Fan,Han Zhao,Mengya Cong et al.
Lu Fan et al.
Background: Multiple myeloma (MM) is a heterogeneous hematological malignancy characterized by the clonal proliferation of plasma cells in the bone marrow, with distinct subtypes including smoldering MM (SMM), newly diagn...
Efficacy of first-line treatment in driver gene-negative non-small cell lung cancer with liver metastases: a Bayesian network meta-analysis [0.03%]
驱动基因阴性非小细胞肺癌伴肝转移一线治疗疗效的贝叶斯网路meta分析
Weiqian Wu,Xiaoyu Guo,Xueqi Dong et al.
Weiqian Wu et al.
Objective: This study aimed to evaluate the first-line treatment patterns and prognostic factors associated with survival in patients with driver gene-negative non-small cell lung cancer (NSCLC) and liver metastases, in o...
Single-cell transcriptomic profiling of bronchial lymph nodes reveals mechanisms of PRRSV escape from host adaptive immunity [0.03%]
单细胞转录组分析揭示支气管淋巴结中PRRSV逃逸宿主适应性免疫的机制
Shu-Yuan Guo,Xuan Wang,Jiaying Zhu et al.
Shu-Yuan Guo et al.
Introduction: Porcine reproductive and respiratory syndrome (PRRS), caused by porcine reproductive and respiratory syndrome virus (PRRSV), is characterized by impaired adaptive immune responses, including persistent virem...
A universally applicable toolbox for single-molecule quantification of chimeric antigen receptors using linker-resolved d STORM microscopy [0.03%]
一种使用链接器解析的dSTORM显微镜对嵌合抗原受体进行单分子定量的通用工具箱
Josefine Michael,Peter Spieler,Fabio Toppeta et al.
Josefine Michael et al.
Chimeric antigen receptor (CAR)-T cell therapies targeting CD19 have demonstrated remarkable clinical efficacy in B-cell malignancies. However, substantial differences exist in therapeutic outcomes, partly due to differences in CAR design a...